| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |